Access cutting-edge chronic lymphocytic leukemia treatment through this clinical trial at a research site in Harrison. Study-provided care at no cost to qualified participants.
Access chronic lymphocytic leukemia specialists in Harrison at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic lymphocytic leukemia treatment provided free
The purpose of this study is to determine the rate of minimum residual disease (MRD) negative response (i.e. the rate of no evidence of disease) of the study drugs, zanubrutinib, obinutuzumab, and venetoclax, given in combination as a treatment for CLL and/or SLL.
Sponsor: Memorial Sloan Kettering Cancer Center
Check if you qualify for this chronic lymphocytic leukemia clinical trial in Harrison, NY
If you're searching for chronic lymphocytic leukemia treatment options in Harrison, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Harrison research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic lymphocytic leukemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.